by hleonhardt | Dec 20, 2024 | News
Dec. 20th, 2024 – Irvine, California –(AINewsworthy)– Leonhardt Ventures LLC is pleased to announce the issuance of U.S. Leonhardt et. al. Patent 12,109,410 with 15 claims entitled “Bioelectric Stimulator”, a significant advancement in the field of...
by hleonhardt | Apr 10, 2023 | News
The First Lady of Nutrition welcomes Howard Leonhardt, the extraordinary founder of Leonhardt Ventures LLC and Lionheart Health, Inc. Leonhardt Ventures is the world’s first Innovation Accelerator focused on the convergence of bioelectrics & biologics for organ...
by hleonhardt | Mar 6, 2023 | Brain, News
DepressiStim TM Reports Progress on Treatment Resistant Depression Pilot Clinical Study The DepressiStim TM Brain Band therapy system is intended to be indicated for adjunctive non-invasive treatment of chronic or recurrent depression in patients who are experiencing...
by hleonhardt | Mar 2, 2023 | News
This new patent letter of allowance received from the USPTO further expands the Company’s intellectual property estate intended for treating, suppressing and preventing cancer tumor formation and progression. Leonhardt Ventures LLC and its cancer treating and...
by hleonhardt | Mar 1, 2023 | News
Strengthens deep pipeline of longevity and wellness intellectual property Leonhardt Ventures LLC, and its commercial distribution arm Lionheart Health, Inc., has filed a series of patent claims for bioelectric controlled expression of the SESTRINs family of anti-aging...
by hleonhardt | Aug 25, 2022 | News
SIRT signaling proteins (1-7) are involved in metabolic regulation, inflammation, neurodegeneration, cell cycle/tumorigenesis, Insulin secretion, DNA repair, and rDNA transcription and play a key role during cell response to a variety of stresses, such as oxidative or...
